Your fact-checks will appear here
Available reporting shows multiple consumer complaints and fact‑checks tying Neurocept-style ads to fabricated endorsements from high‑profile doctors, including Ben Carson, but I found no primary clin...
Available reporting does not identify any clinical drug or supplement named “Neurocept” in peer-reviewed neurology journals, major guideline sites, or clinical-trial roundups included in the search re...
No documentation in the reporting provided shows any regulatory approval or safety warning specifically for a product named “NeuroDefender” in 2025; the authoritative FDA summary pages and contemporan...
Recent public reporting ties “Neurocept” mainly to consumer-supplement coverage and not to peer‑reviewed clinical trial publications; consumer pieces note it operates under dietary supplement rules an...
Available reporting does not show any FDA approval, emergency authorization, or formal U.S. regulatory clearance for a product called “Neurodefender” as of the sources provided; mentions of similar‑na...
There is no single, authoritative clinical-trial portfolio under the name “Neurocept” in the provided reporting; available sources instead show (a) consumer-facing brain‑health supplements marketed as...
Available sources in the provided search results do not mention any drug named “neurocept” or cite regulatory approvals for a product by that name; the assembled reporting instead covers various FDA a...
No identified randomized controlled trials (RCTs) of a drug called “Neurodefender” in adults appear in the provided sources; searches of clinical-trial summaries and recent neurology reporting cited h...
Available sources do not cite any peer‑reviewed randomized clinical trials or regulatory submissions specifically named for a product called “Neurocept”; reporting about Neurocept appears in promotion...
Available reporting and device databases in the provided sources do not list any FDA approvals or clearances specifically for a company named “Neurocept” as of 2025; searches turned up consumer supple...
Available public records in the supplied sources show no FDA device clearance or approval entries for a company or device named “Neurocept,” nor do the supplied clinical-trial–focused sources list reg...
Available sources do not show Neurocept as a prescription drug that underwent an FDA new-drug review; rather, reporting in 2025 treats Neurocept primarily as an over‑the‑counter brain‑health supplemen...
Available sources do not report any FDA authorizations, 510(k) clearances, or PMA submissions specifically attributed to Neurocept Inc. through 2025; searches of the provided FDA and trade-report docu...
Available sources in the provided set do not mention Neurocept or any Neurocept-specific regulatory milestones, FDA interactions, or upcoming data readouts; reporting focuses broadly on FDA approvals,...
The provided analyses consistently report based on the supplied datasets and searches. The conclusion rests on multiple independent checks within the supplied material but is qualified by clear caveat...